- Home
- BTAI vs YGMZ Comparison
BTAI vs YGMZ Comparison
Compare BTAI & YGMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- YGMZ
- Stock Information
- Founded
- BTAI 2017
- YGMZ 2002
- Country
- BTAI United States
- YGMZ China
- Employees
- BTAI N/A
- YGMZ N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- YGMZ Transportation Services
- Sector
- BTAI Health Care
- YGMZ Consumer Discretionary
- Exchange
- BTAI Nasdaq
- YGMZ Nasdaq
- Market Cap
- BTAI 6.6M
- YGMZ 7.0M
- IPO Year
- BTAI 2018
- YGMZ 2020
- Fundamental
- Price
- BTAI $2.13
- YGMZ $0.72
- Analyst Decision
- BTAI Buy
- YGMZ
- Analyst Count
- BTAI 4
- YGMZ 0
- Target Price
- BTAI $37.00
- YGMZ N/A
- AVG Volume (30 Days)
- BTAI 279.4K
- YGMZ 44.8K
- Earning Date
- BTAI 03-11-2025
- YGMZ 01-01-0001
- Dividend Yield
- BTAI N/A
- YGMZ N/A
- EPS Growth
- BTAI N/A
- YGMZ N/A
- EPS
- BTAI N/A
- YGMZ N/A
- Revenue
- BTAI $2,276,000.00
- YGMZ $55,805,416.00
- Revenue This Year
- BTAI $105.36
- YGMZ N/A
- Revenue Next Year
- BTAI $46.93
- YGMZ N/A
- P/E Ratio
- BTAI N/A
- YGMZ N/A
- Revenue Growth
- BTAI 83.25
- YGMZ N/A
- 52 Week Low
- BTAI $2.10
- YGMZ $0.64
- 52 Week High
- BTAI $56.00
- YGMZ $6.24
- Technical
- Relative Strength Index (RSI)
- BTAI 28.68
- YGMZ 44.09
- Support Level
- BTAI $2.18
- YGMZ $0.68
- Resistance Level
- BTAI $2.60
- YGMZ $1.05
- Average True Range (ATR)
- BTAI 0.44
- YGMZ 0.11
- MACD
- BTAI -0.08
- YGMZ -0.00
- Stochastic Oscillator
- BTAI 0.94
- YGMZ 19.66
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About YGMZ MingZhu Logistics Holdings Limited
MingZhu Logistics Holdings Ltd is a Holding company. Its business activities include trucking services and car owner services. Its segments are the trucking business, car owner services business, and liquor distribution business. It generates the majority of its revenue from the trucking segment.